First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: A comparison of enalapril and perindopril

European Journal of Heart Failure

Volumn 2, Issue 3, 2000, Pages 299-304

  Vítovec, Jirí ^a   Špinar, Jindrich ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Congestive heart failure; Enalapril; Hypotension; Perindopril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PERINDOPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HEART DILATATION; HEART FAILURE; HUMAN; HYPOTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOTENSION; INCIDENCE; MALE; MIDDLE AGED; PERINDOPRIL; PROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; STROKE VOLUME;

EID: 0033857310     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(00)00095-7     Document Type: Article

References (22)

1. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
2. ACE inhibitors: A cornerstone of the treatment of heart failure
3. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: A placebo controlled study
4. Angiotensin-converting enzyme inhibition in heart failure: Blood pressure changes after the first dose
5. Changes in blood pressure and heart rate during treatment with the ACE inhibitor spirapril - Comparison of the first dose and chronic use
6. Vasovagal reactions to cardiovascular drugs: The first dose effect
7. Severe hypotension after first dose of enalapril in heart failure
8. Effect of captopril on mortality and morbidity in patients with LVD after myocardial infarction. Results of the survival and enlargement trial
9. Oral captopril versus placebo among 13 634 patients with suspected myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1)
10. A placebo controlled trial of captopril in refractory chronic congestive heart failure
11. The Bezold-Jarisch reflex revisited. Clinical implications of inhibitory reflexes originating in the heart
12. Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease
13. Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?
14. Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors
15. Comparison of captopril and enalapril in patients with severe chronic heart failure
16. Severe hypotension after first dose of enalapril in heart failure
17. 'First dose' hypotension and venodilatation
18. Tissue renin-angiotensin system in myocardial hypertrophy and failure
19. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders